Heart Disease Journals

Cardiology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.